Metabolic imaging predicts neoadjuvant therapy response before pancreatic cancer surgery
The addition of 18-fluorodeoxyglucose to PET provided significant prognostic benefit in objective assessment of neoadjuvant chemotherapy response among patients with borderline resectable/locally advanced pancreatic cancer.The…